Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:55 pm Sale | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 2,346,575 9.99% | -933,901 (-28.47%) | View |
| 2024-02-14 4:32 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Lincoln Park Capital Fund LLC | 1,600,136 0.947% | -209,951 (-11.60%) | View |
| 2024-02-14 4:31 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 116,821 0.375% | -2,253,000 (-95.07%) | View |
| 2024-02-14 4:31 pm Sale | 13G | ENSYSCE BIOSCIENCES INC NE ENSC | Lincoln Park Capital Fund LLC | 124,008 3.792% | -1,377,047 (-91.74%) | View |
| 2024-02-14 4:30 pm Sale | 13G | WINDTREE THERAPEUTIC WINT | Lincoln Park Capital Fund LLC | 339,167 6.181% | -119,875 (-26.11%) | View |
| 2024-02-14 4:29 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 1,307,049 9.676% | 369,461 (+39.41%) | View |
| 2023-06-02 4:46 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 2,369,821 8.98% | 2,369,821 (New Position) | View |
| 2023-04-24 4:33 pm Purchase | 13G | WINDTREE THERAPEUTIC WINT | Lincoln Park Capital Fund LLC | 459,042 9.99% | 459,042 (New Position) | View |
| 2023-02-06 6:34 pm Purchase | 13G | ENSYSCE BIOSCIENCES INC NE ENSC | Lincoln Park Capital Fund LLC | 1,501,055 9.99% | 1,501,055 (New Position) | View |
| 2022-10-25 06:01 am Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Lincoln Park Capital Fund LLC | 937,588 9.99% | -1,376,095 (-59.48%) | View |
| 2022-07-28 5:09 pm Purchase | 13G | KIORA PHARMACEUTICALS INC KPRX | Lincoln Park Capital Fund LLC | 3,280,476 9.99% | 3,280,476 (New Position) | View |
| 2022-05-18 12:34 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Lincoln Park Capital Fund LLC | 1,050,232 9.99% | 1,050,232 (New Position) | View |
| 2022-04-27 10:52 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Lincoln Park Capital Fund LLC | 2,969,718 5.98% | 2,969,718 (New Position) | View |
| 2022-01-19 11:05 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Lincoln Park Capital Fund LLC | 1,810,087 6.44% | 1,810,087 (New Position) | View |
| 2021-11-19 12:57 pm Purchase | 13G | NABRIVA THERAPEUTICS PLC NBRV | Lincoln Park Capital Fund LLC | 4,512,589 7.96% | 4,512,589 (New Position) | View |
| 2021-04-28 5:22 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | Lincoln Park Capital Fund LLC | 423,529 5.392% | 423,529 (New Position) | View |
| 2021-01-15 6:21 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | Lincoln Park Capital Fund LLC | 701,000 9.99% | 701,000 (New Position) | View |
| 2021-01-08 4:38 pm Purchase | 13G | ONCONOVA THERAPEUTICS INC ONTX | Lincoln Park Capital Fund LLC | 13,639,411 6.52% | 13,639,411 (New Position) | View |
| 2020-11-13 06:01 am Purchase | 13G | MOLECULIN BIOTECH INC MBRX | Lincoln Park Capital Fund LLC | 4,787,254 7.52% | 4,787,254 (New Position) | View |
| 2020-08-03 4:03 pm Purchase | 13G | ADVAXIS INC PAR $0.001 ADXS | Lincoln Park Capital Fund LLC | 4,594,793 6.94% | 4,594,793 (New Position) | View |